Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.71 |
| ▸ | TLR7 | Q9NYK1 | 2/20 | 0.69 |
| ▸ | PNP | P00491 | 3/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.44 |
| ▸ | HSPA8 | P11142 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | MTOR | P42345 | 2/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.41 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.41 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | GMNN | O75496 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26079955 | 1.00 | MEN1 (0.71) | MEN1KMT2ATLR7PNPCYP3A4 | |
| SCHEMBL23202083 | 1.00 | MEN1 (0.71) | MEN1KMT2ATLR7PNPCYP3A4 | |
| SCHEMBL10117778 | 1.00 | MEN1 (0.71) | MEN1KMT2ATLR7PNPCYP3A4 | |
| SCHEMBL6448926 | 0.90 | PNP (0.66) | MEN1KMT2ATLR7PNPCYP3A4 | |
| SCHEMBL28692399 | 0.88 | MEN1 (0.72) | MEN1KMT2ATLR7PNPCYP3A4 | |
| SCHEMBL6905072 | 0.87 | TLR7 (0.76) | MEN1KMT2ATLR7PNPCYP3A4 | |
| SCHEMBL7634608 | 0.87 | TLR7 (0.76) | MEN1KMT2ATLR7PNPCYP3A4 | |
| SCHEMBL26079973 | 0.87 | TLR7 (0.76) | MEN1KMT2ATLR7PNPCYP3A4 | |
| SCHEMBL23202214 | 0.87 | TLR7 (0.76) | MEN1KMT2ATLR7PNPCYP3A4 | |
| SCHEMBL23202549 | 0.87 | MEN1 (0.78) | MEN1KMT2ATLR7PNPCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3458 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260139030-A1 | CHIMERIC PROTEINS FOR TREATING CUTANEOUS INFLAMMATION | SHATTUCK LABS INC (US) | 2026-05-21 | — | — | US | claimed |
| US-20250345406-A1 | CHIMERIC PROTEINS IN AUTOIMMUNITY | SHATTUCK LABS INC (US) | 2025-11-13 | — | — | US | claimed |
| US-20250325494-A1 | COMPOSITION FOR ORGAN-SPECIFIC DELIVERY OF NUCLEIC ACID | THEMEDIUM THERAPEUTICS CO., LTD. (CN) | 2025-10-23 | — | — | US | claimed |
| EP-4634380-A1 | INTERNAL RIBOSOME ENTRY SITES FOR IMPROVED POLYNUCLEOTIDE TRANSLATION | ModernaTX, Inc. (US) | 2025-10-22 | — | — | EP | claimed |
| WO-2025137275-A1 | NOVEL CAS NUCLEASES AND POLYNUCLEOTIDES ENCODING THE SAME | MODERNATX, INC. (US) | 2025-06-26 | — | — | WO | claimed |
| US-20250188013-A1 | LIPID COMPOUND AND USE THEREOF | THEMEDIUM THERAPEUTICS CO., LTD. (CN) | 2025-06-12 | — | — | US | claimed |
| WO-2025122721-A1 | CHIMERIC PROTEINS AND USES THEREOF | SHATTUCK LABS, INC. (US) | 2025-06-12 | — | — | WO | claimed |
| EP-4565692-A2 | INTERNAL RIBOSOME ENTRY SITES FOR IMPROVED POLYNUCLEOTIDE TRANSLATION | ModernaTX, Inc. (US) | 2025-06-11 | — | — | EP | claimed |
| WO-2025049610-A1 | MULTI-ACTION PEPTIDES | SHATTUCK LABS, INC. (US) | 2025-03-06 | — | — | WO | claimed |
| CN-119421870-A | Lipid compound and application thereof | 传信生物医药(苏州)有限公司 | 2025-02-11 | — | — | CN | claimed |
| US-20120251618-A1 | DELIVERY AND FORMULATION OF ENGINEERED NUCLEIC ACIDS | modeRNA Therapeutics (US) | 2012-10-04 | — | — | US | claimed |
| CN-101340931-A | Modulation of tlr-mediated immune responses using adaptor oligonucleotides | COLEY PHARM GMBH (DE) | 2009-01-07 | — | — | CN | claimed |
| EP-1928500-A2 | MODULATION OF TLR-MEDIATED IMMUNE RESPONSES USING ADAPTOR OLIGONUCLEOTIDES | Coley Pharmaceutical GmbH (DE) | 2008-06-11 | — | — | EP | claimed |
| WO-2007038720-A2 | MODULATION OF TLR-MEDIATED IMMUNE RESPONSES USING ADAPTOR OLIGONUCLEOTIDES | COLEY PHARMACEUTICAL GMBH (DE) | 2007-04-05 | — | — | WO | claimed |
| US-5317013-A | Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1994-05-31 | — | — | US | claimed |
| US-4948730-A | INDUCING INTERFERON PRODUCTION | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1990-08-14 | — | — | US | claimed |
| US-4746651-A | ANTIBIOTIC AND ALDOGYCOSIDYL-GUANINE OR ISOXANTHOPTERIN IMMUNE RESPONSE-ENHANCING AGENT | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1988-05-24 | — | — | US | claimed |
| US-4643992-A | Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1987-02-17 | — | — | US | claimed |
| EP-0112632-A2 | Use of 8-substituted guanine derivatives in the manufacture of a medicament. | SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) | 1984-07-04 | — | — | EP | claimed |
| WO-1984001898-A1 | MODULATION OF ANIMAL CELLULAR RESPONSES WITH COMPOSITIONS CONTAINNG 8-SUBSTITUTED GUANINE DERIVATIVES | SCRIPPS CLINIC RES (US) | 1984-05-24 | — | — | WO | claimed |